Managing drug discovery alliances for success

G Laroia, S Krishnan - Research-Technology Management, 2005 - Taylor & Francis
OVERVIEW: Although alliances are increasingly important to pharmaceutical companies,
about 60 percent of alliances fail to produce their desired outcomes. Most of these failures …
被引用次数：26 相关文章

Managing Drug Discovery Alliances For Success

G Laroia, S Krishnan - Research-Technology Management, 2005 - ingentaconnect.com
Although alliances are increasingly important to pharmaceutical companies, about 60
percent of alliances fail to produce their desired outcomes. Most of these failures are due to …

MANAGING DRUG DISCOVERY ALLIANCES FOR SUCCESS.

G Laroia, S Krishnan - Research Technology Management, 2005 - search.ebscohost.com
Although alliances are increasingly important to pharmaceutical companies, about 60
percent of alliances fail to produce their desired outcomes. Most of these failures are due to …

MANAGING DRUG DISCOVERY ALLIANCES FOR SUCCESS

G Laroia, S Krishnan - Research Technology Management, 2005 - JSTOR
Although alliances are increasingly important to pharmaceutical companies, about 60
percent of alliances fail to produce their desired outcomes. Most of these failures are due to …

MANAGING DRUG DISCOVERY ALLIANCES FOR SUCCESS

G Laroia, S Krishnan - Research Technology Management, 2005 - search.proquest.com
Although alliances are increasingly important to pharmaceutical companies, about 60% of
alliances fail to produce their desired outcomes. An Analysis of Aventis' portfolio of drug …